Impact Factor
3.52
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
2.78
1,048 total citations
h5-index
36
h5 depth signal
Cited share
73.2%
306 of 418
Total citations
1,048
Citation footprint
Metric signal
2.61
External metric anchor
Self-citation
4.5%
47 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
United States
2,449
South Africa
372
United Kingdom
281
Uganda
212
Canada
201
Citing Fields of Research
HIV
3,051
Immunology
220
Oncology
150
Hepatitis
141
Sexually Transmitted Diseases
136
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
12,756
Articles tracked across the journal lifetime
Indexed publication set
418
306 cited publications
Last 12 months
237
19.8 publications/month
Open access share
25.7%
61 OA publications in the last year
Leading citing country
United States
2,449 citing publications
Leading citing field
HIV
3,051 citing publications
Latest tracked publication
1 November 2026
10 recent records available
Coverage & Indexing History
v21n1, May 1, 1999-
v21n1, May 1, 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
HIV
Broad Categories
Acquired Immunodeficiency Syndrome
HIV
MeSH Descriptors
Acquired Immunodeficiency Syndrome
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1097/qai.0000000000003931
Open DOI
Brief Report: Long-acting Injectable Preexposure Prophylaxis Preference for Persons Who Use Drugs and Are Involved with the Criminal Legal System
Background: criminal legal involved (CLI) persons who use drugs are at high risk of exposure to HIV, yet few initiate preexposure prophylaxis (PrEP). Understanding interest in PrEP and the different formulations of PrEP may improve uptak...
02
DOI 10.1097/qai.0000000000003933
Open DOI
Longitudinal Associations Between Condom Use Self-efficacy Trajectories, HIV-related Stigma, and HIV Prevention Engagement Among Refugee Youth in Kampala, Uganda
Background: Little is known of condom use self-efficacy (CUSE) trajectories over time and associations with HIV prevention engagement. We examined longitudinal associations between CUSE trajectories and HIV prevention engagement, and the...
03
DOI 10.1097/qai.0000000000003932
Open DOI
Weight Trajectories in Virally Suppressed People With HIV Compared With Matched People Without HIV, and Predictors of Weight Gain: A 3-Year Cohort Study From the US TRIO Healthcare Network
Background: Weight gain in people with HIV (PWH) has generated concern regarding the metabolic consequences of antiretroviral therapy (ART). It is unclear whether weight gain differs between virally suppressed (VS) PWH and people without...
04
DOI 10.1097/qai.0000000000003934
Open DOI
Modeling the Potential Impact of Scaling Up Event-Driven PrEP Among Gay, Bisexual, and Other Men Who Have Sex With Men
Background: Event-driven preexposure prophylaxis (PrEP) (EDP), or PrEP taken around the time of sex, could be a preferred option over daily PrEP among cisgender gay, bisexual, and other men who have sex with men (MSM). However, recommend...
05
DOI 10.1097/qai.0000000000003960
Open DOI
Once-Weekly Oral Islatravir Plus Lenacapavir: Clinical Considerations for Individualized Use
Once-weekly oral islatravir plus lenacapavir represents a promising strategy to expand treatment choice for people with HIV (PWH) who prefer oral...
06
DOI 10.1097/qai.0000000000003958
Open DOI
Beyond Body Mass Index: Redefining Obesity Prevalence in an Italian Cohort of People Living With HIV According to the New Lancet Commission's Excess Adiposity Criteria
Was not provided for this article.
07
DOI 10.1097/qai.0000000000003954
Open DOI
Association of Exercise with Body Image Among Older Adults with and Without HIV
Was not provided for this article.
08
DOI 10.1097/qai.0000000000003929
Open DOI
Distinct Transcriptomic Profiles in ART-Treated People With HIV Are Associated With NF-κB–Regulated Gene Expression and Inflammatory Cytokine Signatures
Objective: Despite effective antiretroviral therapy (ART), people with HIV (PWH) continue to experience elevated morbidity, potentially driven by persistent immune dysregulation. This study aimed to define transcriptomic heterogeneity in...
09
DOI 10.1097/qai.0000000000003928
Open DOI
Prevalence and Predictors of Abnormal Cervical Cytology Among Women Living With HIV and Without HIV From the MACS/WIHS Combined Cohort Study
Background: Cervical cancer incidence has markedly declined among US women living with HIV (WLWH) and women without HIV (WWoH). We examined the effects of HIV and immunosuppression on cervical abnormalities in the current antiretroviral ...
10
DOI 10.1097/qai.0000000000003927
Open DOI
Pregnancy and Neonatal Outcomes After Prenatal Exposure to Dolutegravir: Findings from the Antiretroviral Pregnancy Registry
Background: Safe and effective antiretrovirals (ARVs) are essential for managing HIV-1 in pregnant individuals and ensuring positive pregnancy outcomes. International guidelines recommend dolutegravir-based regimens as the preferred opti...
Bibliographical & Catalog Notes
Title from cover.
Supplements accompany some v.
Also issued online.